Endpoint Clinical

Endpoint Clinical is a specialized pharmaceutical company established in 2009, focusing on Interactive Response Technology (IRT) solutions for clinical trials. The company offers comprehensive services including randomization, clinical supply chain management, and electronic patient-reported outcomes (ePRO). With a revenue of $126.0 million and an employee range of 500 - 1,000 individuals, Endpoint Clinical operates within the Healthcare Software and Software Development & Design industries. Its product suite encompasses interactive response technology, high-quality clinical trial management technology, and endpoint solutions designed to streamline complex trial processes. The company's expertise is crucial for pharmaceutical and biotech organizations conducting global clinical research, ensuring data integrity and operational efficiency.

Endpoint Clinical's operational scale and technological capabilities are supported by a dedicated team. Meet Endpoint Clinical's team to understand the expertise driving their innovative solutions. The company's commitment to advancing clinical research is evident in its specialized IRT platform, which facilitates accurate patient randomization and manages the intricate logistics of clinical supply chains. This focus on precision and reliability is vital for sponsors and contract research organizations (CROs) aiming to accelerate drug development timelines and ensure regulatory compliance. Their technology is designed to integrate seamlessly into trial workflows, providing real-time data and control.

The company's market presence is characterized by its deep specialization in IRT, positioning it among key players in the clinical trial technology sector. While specific financial details beyond revenue are not provided, its established revenue figure and employee range indicate a significant operational footprint. Endpoint Clinical's strategic focus on IRT for clinical trials addressesView more...